Can tracking muscle changes unlock better duchenne treatments?

This study follows boys with Duchenne muscular dystrophy who have small mutations in their genes, a group that is less understood than others. Over one year, researchers will use muscle MRI, genetic tests, and motor and respiratory assessments to see how the disease progresses. The goal is to better define the natural history of these patients and to understand how they might respond to mutation-specific therapies like Ataluren. By learning more about these mutations, the study could help tailor future treatments for this specific group.